December 2, 2024
Orthocell’s (ASX:OCC) Remplir™ poised to revolutionise nerve repair surgery
Orthocell’s Remplir™ is set to transform nerve repair surgery by overcoming traditional limitations like inflammation and scarring, offering surgeons a reliable tool for consistent outcomes.